Breaking News Instant updates and real-time market news.

NXTM

NxStage Medical

$27.92

-0.13 (-0.46%)

, FMS

Fresenius Medical

$49.68

-0.33 (-0.66%)

09:06
07/19/18
07/19
09:06
07/19/18
09:06

NxStage sells bloodlines business, sees Fresenius buyout closing in 2018

NxStage Medical (NXTM) disclosed in a regulatory filing this morning that on July 10, it agreed to sell its bloodlines business operated under the Medisystems name to B. Braun Medical. Consummation of the transaction is subject to the Federal Trade Commission's approval of the transaction, the closing of the pending merger of NxStage with a subsidiary of Fresenius Medical Care (FMS) and other customary conditions, NxStage said. It added, "The divestiture agreement was entered into with the goal of advancing the process to obtain FTC clearance of the pending Fresenius Merger under the Hart-Scott-Rodino Act. NxStage continues to expect the Fresenius Merger to close in 2018."

NXTM

NxStage Medical

$27.92

-0.13 (-0.46%)

FMS

Fresenius Medical

$49.68

-0.33 (-0.66%)

NXTM NxStage Medical
$27.92

-0.13 (-0.46%)

08/09/17
SPHN
08/09/17
DOWNGRADE
SPHN
Equal Weight
NxStage Medical downgraded to Equal Weight from Overweight at Stephens
NxStage Medical (NXTM) has agreed to be acquired by Fresenius Medical Care (FMS) for $30 per share.
08/22/17
LEER
08/22/17
DOWNGRADE
LEER
Market Perform
NxStage Medical downgraded to Market Perform from Outperform at Leerink
Leerink analyst Danielle Antalffy downgraded NxStage Medical (NXTM) to Market Perform saying it is unlikely another bidder will top Fresenius Medical's (FMS) $30 per share offer for the company.
08/22/17
08/22/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Mylan (MYL) downgraded to Hold from Buy at Argus with analyst Jasper Hellweg citing the cut in 2017 guidance. He said Mylan may also have difficulty improving operations in the near-term due to unfavorable EpiPen regulatory developments, pricing pressures, and increased competition. 2. Brookfield (BIP) downgraded to Neutral from Outperform at Credit Suisse, with analyst Andrew Kuske saying he is exiting his long "tactical trade" given recent outperformance. 3. Global Medical REIT (GMRE) downgraded to Neutral from Buy at DA Davidson with analyst Barry Oxford saying that the stock "could be range bound for a period of time" following the departures of the REIT's CEO and CFO and due to "potential concerns regarding the dividend and acquisitions." 4. NxStage Medical (NXTM) downgraded to Market Perform from Outperform at Leerink, as analyst Danielle Antalffy said it is unlikely another bidder will top Fresenius Medical's (FMS) $30 per share offer for the company. 5. Hikma (HKMPY) downgraded to Neutral from Buy at Goldman Sachs, with analyst Yulia Gerasimova citing Roxane integration issues, delayed generic Advair approval, ongoing U.S. generics pricing erosion, and multiple guidance downgrades from the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/05/18
CHLM
04/05/18
NO CHANGE
Target $30
CHLM
Hold
CVS focusing on home dialysis positive for NxStage Medical, says Craig-Hallum
Craig-Hallum analyst Kevin Ellich notes that CVS Health (CVS) announced an initiative to improve patient outcomes for chronic kidney disease and dialysis. The analyst believes that a company of CVS Health's size and stature focusing on home dialysis and specifically home hemodialysis is a positive for NxStage Medical (NXTM) since it is the market leader with a huge head start. While there could be concerns about price competition if and when CVS Health is able to get a home hemodialysis device to market, NxStage Medical will have its next generation products to market, as well as a peritoneal dialysis machine, he contends, adding that he thinks the market opportunity will be much larger. Ellich reiterates a Hold rating and $30 price target on NxStage Medical's shares.
FMS Fresenius Medical
$49.68

-0.33 (-0.66%)

04/24/18
DBAB
04/24/18
UPGRADE
DBAB
Buy
Fresenius Medical upgraded to Buy after 10% pullback at Deutsche Bank
Deutsche Bank analyst Gunnar Romer upgraded Fresenius Medical Care to Buy from Hold and raised his price target for the shares to EUR 102 from EUR 83. The stock is down 10% since end of January, mainly due to lackluster guidance communication and concerns around potential reimbursement pressure in the U.S., Romer tells investors in a research note. However, Fresenius Medical's underlying earnings momentum "remains healthy" and potential reimbursement pressure appears manageable, the analyst contends.
07/05/18
FBCO
07/05/18
DOWNGRADE
FBCO
Neutral
Fresenius Medical downgraded to Neutral from Outperform at Credit Suisse
07/05/18
07/05/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Munich Re (MURGY) downgraded to Neutral from Overweight at JPMorgan. 2. Domino's Pizza Enterprises (DPZUF) downgraded to Sell from Neutral at Citi. 3. NextEra Energy downgraded to Market Perform from Outperform at Raymond James with analyst Pavel Molchanov saying NextEra's 3.6% yield is the lowest among yieldcos and he recommends waiting for a better entry point. 4. Clean Energy (CLNE) downgraded to Underperform from Market Perform at Raymond James with analyst Pavel Molchanov saying he believes shares reflect "excessive euphoria" over the partnership with Total (TOT). 5. Fresenius Medical (FMS) downgraded to Neutral from Outperform at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/09/18
BOFA
07/09/18
INITIATION
BOFA
Buy
Fresenius Medical reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Patrick Wood reinstated coverage of Fresenius Medical with a Buy rating and price target of EUR 102. The analyst views the shares as attractively valued and believes the potential extension of Medicare Secondary Payer currently attached to the Senate opioid bill could be worth around EUR 18 per share.

TODAY'S FREE FLY STORIES

NBIX

Neurocrine

$87.40

-12.25 (-12.29%)

14:38
11/14/18
11/14
14:38
11/14/18
14:38
Periodicals
Neurocrine tells Bloomberg no link between drug, deaths in FDA database »

Neurocrine Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

FBP

First BanCorp

$9.04

-0.29 (-3.11%)

14:35
11/14/18
11/14
14:35
11/14/18
14:35
Hot Stocks
Breaking Hot Stocks news story on First BanCorp »

First Bancorp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGS

PagSeguro Digital

$22.84

0.215 (0.95%)

, EDU

New Oriental Education

$58.48

0.31 (0.53%)

14:33
11/14/18
11/14
14:33
11/14/18
14:33
Hot Stocks
Tiger Management takes new stake in PagSeguro, adds to Alibaba stake in Q3 »

Tiger Management…

PAGS

PagSeguro Digital

$22.84

0.215 (0.95%)

EDU

New Oriental Education

$58.48

0.31 (0.53%)

RDFN

Redfin

$15.48

-0.12 (-0.77%)

FOXA

21st Century Fox

$48.11

0.39 (0.82%)

AMZN

Amazon.com

$1,615.00

-16.68 (-1.02%)

MDLZ

Mondelez

$43.61

-0.48 (-1.09%)

BABA

Alibaba

$149.84

3.01 (2.05%)

CSCO

Cisco

$44.84

-0.29 (-0.64%)

MSFT

Microsoft

$105.43

-1.04 (-0.98%)

NXPI

NXP Semiconductors

$81.77

-0.01 (-0.01%)

BX

Blackstone

$32.95

-0.4 (-1.20%)

BOOT

Boot Barn

$22.61

-2.225 (-8.96%)

JPM

JPMorgan

$107.15

-2.44 (-2.23%)

SPOT

Spotify

$132.90

1.21 (0.92%)

RCL

Royal Caribbean

$106.31

0.06 (0.06%)

DAL

Delta Air Lines

$56.58

-0.23 (-0.40%)

ADBE

Adobe

$235.27

-3.58 (-1.50%)

GOOG

Alphabet

$1,044.10

7.77 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 19

    Nov

  • 26

    Nov

  • 28

    Nov

  • 28

    Nov

  • 29

    Nov

  • 04

    Dec

  • 12

    Dec

  • 10

    Jan

  • 26

    Feb

  • 03

    Mar

FBP

First BanCorp

$9.01

-0.32 (-3.43%)

14:28
11/14/18
11/14
14:28
11/14/18
14:28
Hot Stocks
First BanCorp reinstates quarterly cash dividend of 3c per share »

First BanCorp., the bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AG

First Majestic

$5.20

0.325 (6.67%)

14:25
11/14/18
11/14
14:25
11/14/18
14:25
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$268.71

-3.29 (-1.21%)

, SPX

S&P 500

$0.00

(0.00%)

14:23
11/14/18
11/14
14:23
11/14/18
14:23
General news
May says Brexit decision 'in best interest of entire United Kingdom' »

UK Prime Minister Theresa…

SPY

SPDR S&P 500 ETF Trust

$268.71

-3.29 (-1.21%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$268.76

-3.24 (-1.19%)

, SPX

S&P 500

$0.00

(0.00%)

14:23
11/14/18
11/14
14:23
11/14/18
14:23
General news
May says collective decision was to back Brexit deal »

Theresa May said "I…

SPY

SPDR S&P 500 ETF Trust

$268.76

-3.24 (-1.19%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$268.67

-3.33 (-1.22%)

, SPX

S&P 500

$0.00

(0.00%)

14:20
11/14/18
11/14
14:20
11/14/18
14:20
General news
Theresa may has cabinet support for Brexit plan, Telegraph says »

The Telegraph's…

SPY

SPDR S&P 500 ETF Trust

$268.67

-3.33 (-1.22%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBP

First BanCorp

$8.98

-0.35 (-3.75%)

14:17
11/14/18
11/14
14:17
11/14/18
14:17
Hot Stocks
Breaking Hot Stocks news story on First BanCorp »

First Bancorp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/14/18
11/14
14:17
11/14/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:17
11/14/18
11/14
14:17
11/14/18
14:17
Conference/Events
Bernstein transportation analysts to hold an analyst/industry conference call »

European Transportation…

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/14/18
11/14
14:16
11/14/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FITB

Fifth Third

$26.79

-0.91 (-3.29%)

14:15
11/14/18
11/14
14:15
11/14/18
14:15
Options
Fifth Third put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BUD

AB InBev

$76.46

3.23 (4.41%)

14:05
11/14/18
11/14
14:05
11/14/18
14:05
Options
Anheuser Busch call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

AQMS

Aqua Metals

$2.47

-0.02 (-0.80%)

, JCI

Johnson Controls

$33.25

-1.54 (-4.43%)

14:02
11/14/18
11/14
14:02
11/14/18
14:02
Hot Stocks
Aqua Metals announces official vendor certification from Johnson Controls »

Aqua Metals (AQMS)…

AQMS

Aqua Metals

$2.47

-0.02 (-0.80%)

JCI

Johnson Controls

$33.25

-1.54 (-4.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFN

Infinera

$4.42

0.02 (0.45%)

13:56
11/14/18
11/14
13:56
11/14/18
13:56
Hot Stocks
Infinera CFO Brad Feller buys 40K shares of company stock »

Infinera CFO Brad Feller…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$13.21

-0.68 (-4.90%)

13:55
11/14/18
11/14
13:55
11/14/18
13:55
Options
GameStop put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

LBRDA

Liberty Broadband

$82.54

0.02 (0.02%)

13:55
11/14/18
11/14
13:55
11/14/18
13:55
Conference/Events
Liberty Broadband to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

APRN

Blue Apron

$1.15

-0.07 (-5.74%)

13:52
11/14/18
11/14
13:52
11/14/18
13:52
Downgrade
Blue Apron rating change  »

Blue Apron downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

GOOS

Canada Goose

$63.55

4.95 (8.45%)

13:46
11/14/18
11/14
13:46
11/14/18
13:46
Recommendations
Canada Goose analyst commentary  »

Canada Goose price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

COG

Cabot Oil & Gas

$25.96

-0.54 (-2.04%)

13:40
11/14/18
11/14
13:40
11/14/18
13:40
Options
Aggressive call buying in Cabot Oil and Gas »

Aggressive call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

ACU

Acme United

$16.35

-1.03 (-5.93%)

13:38
11/14/18
11/14
13:38
11/14/18
13:38
Hot Stocks
Acme United raises quarterly dividend 9% to 12c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$143.10

0.91 (0.64%)

13:34
11/14/18
11/14
13:34
11/14/18
13:34
Periodicals
Facebook morale takes hit amid challenging year, WSJ reports »

Facebook's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

ERIC

Ericsson

$8.55

-0.37 (-4.15%)

13:33
11/14/18
11/14
13:33
11/14/18
13:33
Periodicals
Ericsson CEO not seeing sales boost as security worries hit rivals, Reuters says »

Ericsson CEO Borje Ekholm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 26

    Nov

BMWYY

BMW

$0.00

(0.00%)

, VOD

Vodafone

$20.26

0.17 (0.85%)

13:30
11/14/18
11/14
13:30
11/14/18
13:30
Periodicals
BMW, Vodafone, Ericsson urge EU to weigh 5G car technology, Reuters says »

BMW (BMWYY), Vodafone…

BMWYY

BMW

$0.00

(0.00%)

VOD

Vodafone

$20.26

0.17 (0.85%)

ERIC

Ericsson

$8.55

-0.37 (-4.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 26

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.